Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516199 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Otelixizumab (GSK2136525, TRX4, ChAglyCD3) - R & D Biopharmaceutical & Pharmaceutical Product Profile

BioPolaris, March 2010, Pages: 2


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Otelixizumab (GSK2136525, TRX4, ChAglyCD3) - R & D Biopharmaceutical & Pharmaceutical Product.

Otelixizumab (GSK2136525, TRX4, ChAglyCD3) is a late-stage R & D therapeutic product.

Sources of Information:

Research data published in this product profile are obtained primarily from companies involved in its development. In addition, the analyst used other available sources of information, including database of the US National Institutes of Health (NIH).

Rarely, and only when necessary, information was based on published scientific articles.



Customers who bought this item also bought

Albiglutide - R & D Biopharmaceutical & Pharmaceutical Product Profile

UNI-rE-4 (rExendin-4) - R & D Biopharmaceutical & Pharmaceutical Product Profile

Competitor Analysis - Cancer Antibodies in Early Clinical Development

Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report

HDV-Insulin (HDV-I) - R & D Biopharmaceutical & Pharmaceutical Product Profile

LY2189265 - R & D Biopharmaceutical & Pharmaceutical Product Profile

Ranirestat (AS-3201) - R & D Biopharmaceutical & Pharmaceutical Product Profile

Rivoglitazone (CS-011, DE-101) - R & D Biopharmaceutical & Pharmaceutical Product Profile

Alogliptin (SYR-322) - R & D Biopharmaceutical & Pharmaceutical Product Profile

Balaglitazone (DRF 2593, NN2344) - R & D Biopharmaceutical & Pharmaceutical Product Profile
For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds